Boston Scientific Corporation (BSX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 87.55 |
| Open | 87.80 |
| Bid | 86.39 x 1100 |
| Ask | 87.00 x 1100 |
| Day's range | 86.50 - 88.09 |
| 52-week range | 49.15 - 88.09 |
| Volume | |
| Avg. volume | 5,567,146 |
| Market cap | 127.78B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 70.54 |
| EPS (TTM) | 1.23 |
| Earnings date | 23 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 89.83 |
Investor's Business DailySolventum Stock Earns 81 RS Rating
Solventum stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 78 to 81. The healthcare solutions stock debut Mar. 26. IBD's proprietary rating measures market leadership with a 1 (worst) to 99 (best) score.
ZacksReasons to Retain PacBio Stock in Your Portfolio for Now
PACB's strong product demand and continued focus on R&D raise optimism about the stock.
Zacks3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX)
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
© 2024 Yahoo. All rights reserved.